Lumicell Expands New Headquarters for Molecular Imaging

Lumicell Inc., a technology leader in the field of image-guided cancer surgery, has expanded its new headquarters in Newton, Mass., into a contemporary workspace where the company’s molecular imaging technology will be developed.

The new office space at One Newton Place, 275 Washington St., has a footprint of more than 20,000 square feet and has been completely renovated to meet Lumicell’s needs. The building’s close proximity to downtown Boston and Cambridge, from where much of its research and development team hails, is an ideal location, company leaders said.

“This space represents a huge growth milestone for Lumicell,” said Kelly Londy, CEO of Lumicell. “As we grow into more oncology indications and future health care projects, we now have an office environment that supports the expansion of our platform. Every decision for this space was focused on efficiency, collaboration, and technology that pushes engineering solutions to positively impact patients and clinicians. In fact, we have room for clinical trainings and education events with medical teams from hospitals and local universities who work collaboratively with our team.”

The company’s lead product, the Lumicell System, is in late-stage development for breast cancer surgery. It features an investigational optical agent and a hand-held device that enable cancer surgeons to see and remove cancer cells in real-time during operations. The Lumicell System was designed and developed by MIT engineers in partnership with leading breast cancer surgeons to fit seamlessly within the existing surgical workflow.